Last updated on October 2017

A Study to Investigate Efficacy Safety Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of Female Subjects With Bladder Pain Syndrome/Interstitial Cystitis


Brief description of study

The purpose of this study is to investigate efficacy, safety and tolerability of ASP6294 in female participants with Bladder Pain Syndrome/Interstitial Cystitis (BPS/IC). This study will also investigate the pharmacokinetics (PK) and pharmacodynamics (PD) of ASP6294 in female participants with BPS/IC.

Clinical Study Identifier: NCT03282318

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Clinical Science

Site CZ42003
Praha 4, Czechia
  Connect »

Clinical Science

Site LV37103
Daugavpils, Latvia
  Connect »

Clinical Science

Site LV37101
Riga, Latvia
  Connect »

Clinical Science

Site LV37102
Riga, Latvia
  Connect »

Clinical Science

Site LV37105
Riga, Latvia
  Connect »